Key Drivers
- Strong Cash Flow
- Rising Leverage
- Adequate Liquidity
AIAI Summary
SNN is now a turnaround-and-execution investment: its resilient cash generation and lower valuation offer upside only if management restores organic growth and stabilizes guidance, while higher-cost refinancing and rising leverage leave little room for further operational misses.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Cash Flow
- •Rising Leverage
- •Adequate Liquidity
SNN combines strong margins and cash conversion with a more attractive valuation, but rising leverage and weakening liquidity warrant close monitoring.
Price Behavior
Key Price Behavior Insights:
- •Persistent downtrend
- •Critical support
- •Weak momentum
SNN is in a cautious downtrend, down 5.1% over the last month and below its average, with $27.50 support critical and resistance at $28.40–$28.90.
5.1% decline over the last month signals sustained selling pressure
Sentiment & News
Key News Insights:
- •Guidance pressure
- •Analyst downgrades
- •BlackRock stake
Smith & Nephew faces heightened execution and guidance risks despite undervaluation support, institutional buying, and debt-management actions.
Near-term sentiment remains cautious, with recovery dependent on improved execution and credible delivery against revised guidance
Similar Companies in Healthcare
Other companies in the same sector with AI ratings